Health Net, Inc. says in its latest quarterly report filed with the U.S. Securities and Exchange Commission dated Aug. 8, 2008, that the investigation of the Attorney General of California regarding rescissions and related activities is still ongoing.
In recent…
Forest Laboratories, Inc. is named in 70 product liability lawsuits for the period ended June 30, 2008, according to the Company’s latest quarterly report filed with the Securities and Exchange Commission.
More than 40 of the lawsuits allege that Celexa…
The U.S. Securities and Exchange Commission’s investigation into Cardinal Health Inc.’s Executive Chairman of the Board, as well as four former officers and employees, is ongoing.
On Oct. 7, 2003, the Company received a request from the SEC relating to…
Cardinal Health Inc. continues cooperating with the state attorney general offices of Illinois and New York regarding their investigations into a program on repackaged pharmaceuticals.
In October 2005, the Company received a subpoena from the Attorney General’s Office of the State…
Cardinal Health Inc., during the quarter ended June 30, 2008, received the remaining US$35.0 million in net proceeds from the settlement of the derivative actions filed against the Company and certain of its directors and officers.
On Nov. 8, 2002,…
Valeant Pharmaceuticals International, in its Form 10-Q dated Aug. 11, 2008, disclosed that it expects to be dismissed with prejudice from Kathleen M. O’Connor’s product liability lawsuit on Permax soon.
On Feb. 8, 2007, the Company was served with the…
Cardinal Health Inc. and the Drug Enforcement Administration of the U.S. Department of Justice, on Aug. 7, 2008, reached an oral agreement in principle to resolve the license suspensions.
The agreement is subject to the completion of definitive documentation as…